DK1426355T3 - Krystaller af hydroxynorephedrinderivater - Google Patents

Krystaller af hydroxynorephedrinderivater

Info

Publication number: DK1426355T3
Authority: DK; Denmark
Prior art keywords: crystals; hydroxynorephedrine; derivatives; hydroxynorephedrine derivatives; methylethylüaminoüethylü
Prior art date: 2001-09-13

Application number

DK02765352T

Other languages

Danish (da)

English (en)

Inventor

Hidetoshi Isawa

Yukihiko Hotei

Kiyoshi Kasai

Junichi Sonehara

Satoshi Akahane

Hiromu Harada

Original Assignee

Kissei Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-13

Filing date

2002-08-27

Publication date

2009-02-23

2002-08-27 Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical

2009-02-23 Application granted granted Critical

2009-02-23 Publication of DK1426355T3 publication Critical patent/DK1426355T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK02765352T 2001-09-13 2002-08-27 Krystaller af hydroxynorephedrinderivater DK1426355T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001277345		2001-09-13
PCT/JP2002/008596 WO2003024916A1 (fr)	2001-09-13	2002-08-27	Cristaux d'un derive d'hydroxynorephedrine

Publications (1)

Publication Number	Publication Date
DK1426355T3 true DK1426355T3 (da)	2009-02-23

Family

ID=19101883

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02765352T DK1426355T3 (da)	2001-09-13	2002-08-27	Krystaller af hydroxynorephedrinderivater

Country Status (29)

Country	Link
US (1)	US7208520B2 (fr)
EP (1)	EP1426355B1 (fr)
JP (1)	JP4157036B2 (fr)
KR (2)	KR20080098691A (fr)
CN (1)	CN1275936C (fr)
AT (1)	ATE411276T1 (fr)
AU (1)	AU2002330453B2 (fr)
BR (1)	BR0212494A (fr)
CA (1)	CA2458544C (fr)
CO (1)	CO5560555A2 (fr)
CY (1)	CY1109409T1 (fr)
DE (1)	DE60229404D1 (fr)
DK (1)	DK1426355T3 (fr)
EA (1)	EA006022B1 (fr)
EC (1)	ECSP045017A (fr)
ES (1)	ES2314092T3 (fr)
HK (1)	HK1070051A1 (fr)
HR (1)	HRP20040250A2 (fr)
HU (1)	HUP0401694A3 (fr)
IL (2)	IL160681A0 (fr)
MX (1)	MXPA04002449A (fr)
NO (1)	NO328252B1 (fr)
NZ (1)	NZ531602A (fr)
PL (1)	PL206246B1 (fr)
PT (1)	PT1426355E (fr)
SI (1)	SI1426355T1 (fr)
UA (1)	UA77000C2 (fr)
WO (1)	WO2003024916A1 (fr)
ZA (1)	ZA200401757B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
CA2524023C (fr) *	2003-05-05	2011-11-22	Kissei Pharmaceutical Co., Ltd.	Utilisation de derives de l'acide phenoxyacetique en vue du traitement d'une vessie hyperactive
DE10351271A1 (de) *	2003-10-31	2005-06-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz
EP1682183A2 (fr) *	2003-11-03	2006-07-26	Boehringer Ingelheim International Gmbh	Composition pharmaceutique contenant un agoniste des recepteurs beta-3-adrenergiques et un antagoniste alpha et/ou un inhibiteur de la 5-alpha-reductase
DE10352132A1 (de) *	2003-11-04	2005-06-09	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
JP4808613B2 (ja) *	2004-03-24	2011-11-02	キッセイ薬品工業株式会社	頻尿または尿失禁の予防または治療用医薬
WO2005092321A1 (fr) *	2004-03-24	2005-10-06	Kissei Pharmaceutical Co., Ltd.	Composition pharmaceutique pour la prevention ou le traitement de la frequence urinaire accrue ou de l’urination involontaire
EP1612203B1 (fr) *	2004-06-28	2007-08-01	Grünenthal GmbH	Formes cristallines de chlorhydrate de (-)-(1R,2R)-3-(3-diméthylamino-1-ethyl-2-méthylpropyl)-phénol
DE102004050952A1 (de) *	2004-10-18	2006-04-20	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind
WO2006042679A1 (fr) *	2004-10-18	2006-04-27	Boehringer Ingelheim International Gmbh	Utilisation d'un agoniste beta 3 pour traiter des douleurs de la prostate et du tractus uro-genital inferieur
WO2006045519A1 (fr)	2004-10-26	2006-05-04	Kissei Pharmaceutical Co., Ltd.	Synthese de derives d'acide phenoxy-acetique
TWI356699B (en) *	2004-11-10	2012-01-21	Kissei Pharmaceutical	Agent for treating interstitial cystitis and agent
US7763654B2 (en)	2005-04-26	2010-07-27	Kissei Pharmaceutical Co., Ltd.	Crystal polymorph of hydroxynorephedrin derivative hydrochloride
CA2605298A1 (fr) *	2005-04-26	2006-11-09	Kissei Pharmaceutical Co., Ltd.	Cristal de chlorhydrate de derive d'hydroxynorephedrine 1/4 hydrate
EP1769792A1 (fr)	2005-09-30	2007-04-04	Boehringer Ingelheim Pharma GmbH & Co.KG	Utilisation d'un du récepteur béta-3-adrénergique pour le traitement des troubles rénaux et vésicaux
EP2197532A1 (fr)	2007-08-06	2010-06-23	Serenity Pharmaceuticals Corporation	Procédés et dispositifs pour l'administration de médicament desmopressine
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
ES2462465T5 (es)	2008-05-21	2018-02-28	Ferring B.V.	Desmopresina bucodispersable para aumentar el periodo inicial del sueño no alterado por nocturia
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY126489A (en) *	1998-07-08	2006-10-31	Kissei Pharmaceutical	Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP4005731B2 (ja) *	1999-01-21	2007-11-14	キッセイ薬品工業株式会社	アミノエチルフェノキシ酢酸誘導体の結晶多形
JP4005729B2 (ja) *	1999-01-21	2007-11-14	キッセイ薬品工業株式会社	アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JP4005730B2 (ja) *	1999-01-21	2007-11-14	キッセイ薬品工業株式会社	アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形

2002
- 2002-08-27 UA UA2004031852A patent/UA77000C2/uk unknown
- 2002-08-27 DK DK02765352T patent/DK1426355T3/da active
- 2002-08-27 EA EA200400311A patent/EA006022B1/ru not_active IP Right Cessation
- 2002-08-27 WO PCT/JP2002/008596 patent/WO2003024916A1/fr active IP Right Grant
- 2002-08-27 BR BR0212494-7A patent/BR0212494A/pt not_active IP Right Cessation
- 2002-08-27 ES ES02765352T patent/ES2314092T3/es not_active Expired - Lifetime
- 2002-08-27 AT AT02765352T patent/ATE411276T1/de active
- 2002-08-27 IL IL16068102A patent/IL160681A0/xx unknown
- 2002-08-27 DE DE60229404T patent/DE60229404D1/de not_active Expired - Lifetime
- 2002-08-27 JP JP2003528764A patent/JP4157036B2/ja not_active Expired - Fee Related
- 2002-08-27 PL PL367874A patent/PL206246B1/pl not_active IP Right Cessation
- 2002-08-27 KR KR1020087026126A patent/KR20080098691A/ko not_active Application Discontinuation
- 2002-08-27 MX MXPA04002449A patent/MXPA04002449A/es active IP Right Grant
- 2002-08-27 AU AU2002330453A patent/AU2002330453B2/en not_active Ceased
- 2002-08-27 KR KR1020047003545A patent/KR100874952B1/ko not_active IP Right Cessation
- 2002-08-27 SI SI200230775T patent/SI1426355T1/sl unknown
- 2002-08-27 CN CNB028175964A patent/CN1275936C/zh not_active Expired - Fee Related
- 2002-08-27 US US10/489,343 patent/US7208520B2/en not_active Expired - Fee Related
- 2002-08-27 CA CA2458544A patent/CA2458544C/fr not_active Expired - Fee Related
- 2002-08-27 PT PT02765352T patent/PT1426355E/pt unknown
- 2002-08-27 EP EP02765352A patent/EP1426355B1/fr not_active Expired - Lifetime
- 2002-08-27 HU HU0401694A patent/HUP0401694A3/hu unknown
2003
- 2003-08-27 NZ NZ531602A patent/NZ531602A/en not_active IP Right Cessation
2004
- 2004-03-02 IL IL160681A patent/IL160681A/en not_active IP Right Cessation
- 2004-03-03 ZA ZA200401757A patent/ZA200401757B/en unknown
- 2004-03-12 CO CO04022925A patent/CO5560555A2/es not_active Application Discontinuation
- 2004-03-12 HR HR20040250A patent/HRP20040250A2/hr not_active Application Discontinuation
- 2004-03-12 EC EC2004005017A patent/ECSP045017A/es unknown
- 2004-03-12 NO NO20041060A patent/NO328252B1/no not_active IP Right Cessation
2005
- 2005-04-04 HK HK05102803A patent/HK1070051A1/xx not_active IP Right Cessation
2009
- 2009-01-14 CY CY20091100027T patent/CY1109409T1/el unknown

Also Published As

Publication number	Publication date
EA200400311A1 (ru)	2004-08-26
BR0212494A (pt)	2004-08-24
AU2002330453B2 (en)	2008-04-17
DE60229404D1 (de)	2008-11-27
ATE411276T1 (de)	2008-10-15
EP1426355A4 (fr)	2006-03-29
US7208520B2 (en)	2007-04-24
CO5560555A2 (es)	2005-09-30
KR20080098691A (ko)	2008-11-11
HUP0401694A3 (en)	2008-03-28
SI1426355T1 (sl)	2009-02-28
CA2458544C (fr)	2010-08-17
CY1109409T1 (el)	2014-07-02
MXPA04002449A (es)	2004-07-23
CA2458544A1 (fr)	2003-03-27
HRP20040250A2 (en)	2005-02-28
EP1426355A1 (fr)	2004-06-09
IL160681A0 (en)	2004-08-31
CN1275936C (zh)	2006-09-20
HK1070051A1 (en)	2005-06-10
ZA200401757B (en)	2005-03-03
WO2003024916A1 (fr)	2003-03-27
HUP0401694A2 (hu)	2004-11-29
UA77000C2 (en)	2006-10-16
JPWO2003024916A1 (ja)	2004-12-24
ES2314092T3 (es)	2009-03-16
ECSP045017A (es)	2004-09-27
EA006022B1 (ru)	2005-08-25
CN1553890A (zh)	2004-12-08
PL367874A1 (en)	2005-03-07
KR20040044881A (ko)	2004-05-31
NO20041060L (no)	2004-06-11
IL160681A (en)	2010-06-16
NZ531602A (en)	2006-01-27
PT1426355E (pt)	2008-11-03
NO328252B1 (no)	2010-01-18
KR100874952B1 (ko)	2008-12-19
JP4157036B2 (ja)	2008-09-24
US20040242686A1 (en)	2004-12-02
EP1426355B1 (fr)	2008-10-15
PL206246B1 (pl)	2010-07-30

Publication	Publication Date	Title
DK1426355T3 (da)	2009-02-23	Krystaller af hydroxynorephedrinderivater
MXPA04002167A (es)	2004-06-29	Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
IS2750B (is)	2011-08-15	Leiðarafesting
NO20020968L (no)	2002-04-26	Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
CY1109880T1 (el)	2014-09-10	ΑΝΤΑΓΩΝΙΣΤΗΣ CaSR
BR0210383A (pt)	2006-04-04	compostos para o tratamento de distúrbios metabólicos
PT1259489E (pt)	2006-08-31	Compostos azapoliciclicos condensados con arilo.
SE0201544D0 (sv)	2002-05-17	Novel compounds and thier use
DK1767535T3 (da)	2010-04-12	Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
BRPI0513672A (pt)	2008-05-13	processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
NO304113B1 (no)	1998-10-26	Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
CY1111857T1 (el)	2015-11-04	Κρυσταλλικη βαση trans-1-((1r,3s)-6-xλωpo-3-φαινυλινδαν-1-υλο)-3,3-διμεθυλοπιπεραζινης
WO2004041802A8 (fr)	2005-03-10	Derives de 4(phenyl-piperazinyl-methyl) benzamide et utilisation de ceux-ci pour le traitement de la douleur et des troubles gastro-intestinaux
WO2000056315A8 (fr)	2001-06-21	Traitement de la douleur
IS6087A (is)	2001-09-26	N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
BR0114395A (pt)	2005-08-16	Composição farmacêutica para administração por suprimento via oral
SE0104333D0 (sv)	2001-12-19	Therapeutic agents
NO20050903L (no)	2005-04-18	Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
BRPI0513549A (pt)	2008-05-06	composições farmacêuticas para o tratamento de leishmaniose
ATE295845T1 (de)	2005-06-15	Prucaloprid-n-oxid
MXPA01009461A (es)	2004-03-19	Tratamiento de osteoartritis.
DK1496904T3 (da)	2007-11-12	Anvendelse af lægemidler indeholdende N,N'-disubstituerede piperazinforbindelser
ITTO20040343A1 (it)	2004-08-24	Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo
UA84544C2 (ru)	2008-11-10	Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида